MIR155HG and breast carcinoma: To corroborate the above finding that miR-155 overexpression in breast cancer cells helps flood the tumor with antitumor immune cells, we performed an unbiased multiplex proinflammatory chemokine panel assay to determine the secretome difference between EO771-GFP and EO771-Bic cells.